Johnson & Johnson EO-Notes 2025(25/33)
- BID
97.829
- ASK
97.955
- 1,000,000 Nom.500,000 Nom.
- 07/28, 16:17:32 PM
Type of financial instrument
Corporate Bond
Sub-Type
Health Care
Yield
3.43
Yield spread Bundesanleihe
0.4288
Tradable for private investors
No
Minimum amount tradeable unit
100,000.00
Maturity
26/02/2033
Interest Rate
3.05 %
Currency
Euro
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE / YIELD | 97.826 G / 3.43 | 0 Units |
| PRICE DETERMINATION TIME | 07/28/2026 / 04:06:17 PM | |
| DAILY VOLUME (NOMINAL) | 0 | |
| YIELD SPREAD | 0.4288 | |
| FIXINGPRICE | - | |
| DAILY HIGH / LOW | 97.955 | 97.814 |
| PREV. DAY'S PRICE | 97.782 | (07/27) |
| CHANGE DAY BEFORE | +0.04 | 0.04 % |
| 52 WEEK HIGH / LOW | 101.675 (10/28) | 97 (03/27) |
Master Data
| WKN | A4D7EZ |
| ISIN | XS3005214369 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Corporate Bond |
| SUB-TYPE | Health Care |
| ISSUER | Johnson & Johnson Corp. |
| S&P RATING | Please log in to view this field |
| (TRADING) SEGMENT / TICKS | -/ - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| INTEREST RATE | 3.05 % |
| INTEREST RUN FROM | 26/02/2025 |
| NEXT INTEREST PAYMENT | 17/02/2027 |
| UNIT INTEREST FROM NOMINAL AMMOUNT | 1.362 % |
| TRADING CURRENCY / NOTATION | Euro/ Percent |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| QUOTATION | Continuous trading |
| ISSUING VOLUME | 700.00 Mil. |
| MINIMUM AMOUNT TRADEABLE UNIT | 100,000.00 |
| SMALLEST TRADEABLE UNIT | 1,000.00 |
| MATURITY | 26/02/2033 |
| MARKET MAKER | - |
| STEP UP/ DOWN WHEN RATING CHANGES | No |
| STEP UP FIXED AT ISSUE | No |
| STEP DOWN FIXED AT ISSUE | No |
| BOND CALLABLE BY THE ISSUER | Yes |
| BOND IS SUBORDINATED | No |
Description
Callable bond.
Tradability Information
Please log in to see the tradability information for this stock.Not registered yet? Create your free account here.
Company profile
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.